2 September 2024, LONDON — Exponent, a leading European private equity firm, today announced that it has received official approval of its near-term emissions reduction target from the Science Based Targets initiative (SBTi).

The validated Science Based Target commits Exponent to:

• Reduce direct (Scope 1 and 2) emissions by 42% by 2030
• Ensure 46% of our portfolio (by invested capital) has a science-based target in place by 2028
• Achieve 100% portfolio coverage with science-based targets by 2035

Lizzie Stazicker, ESG Director at Exponent, said: “When setting our climate ambition, it was essential that our goals align with the latest climate science and the objectives of the Paris Agreement to limit global warming to 1.5°C. This validation marks a significant milestone for Exponent and underlines our deep commitment to responsible investment and long-term value creation. We see decarbonisation as a critical lever in building more resilient businesses and delivering sustainable returns for our investors. Over the coming years, we will continue to work closely with our portfolio companies to support them in setting and delivering on science-based targets.”

More details about Exponent’s target and approach are available in the full summary provided by SBTi:

https://files.sciencebasedtargets.org/production/files/Target-language-and-summary_Exponent_Private_Equity.pdf